2020 ASCO Virtual Direct™ Highlights

 

2020 ASCO Virtual Direct™ Highlights
Avatar

2020 ASCO Update on Resectable Stage III Melanoma: Can We Avoid TLND With Neoadjuvant Ipilimumab + Nivolumab?

By 2020 ASCO Virtual Direct™ Highlights FEATURING Marlana Orloff
By 2020 ASCO Virtual Direct™ Highlights FEATURING Marlana Orloff
48 views
August 20, 2020
0 Comments
Login to view comments. Click here to Login

Featured Video

20:59
Exelixis

Primary Analysis and Follow-up Data of a Combination Therapy in 1L a…

Feat. S. Ratnam

Featured Video

06:51
Insights from 2023 ASH Annual Meeting

ASH 2023 Insights: "Prevalence and Prediction of Ruxolitinib Tr…

Feat. D. Tremblay
Skin
12:19
2020 ASCO Virtual Direct™ Highlights

2020 ASCO Highlights on Melanoma: How Effective Is the Combination o…

Feat. M. Orloff
08:06
2020 ASCO Virtual Direct™ Highlights

2020 ASCO Update on Resectable Stage III Melanoma: Can We Avoid TLND…

Feat. M. Orloff
04:41
2020 ASCO Virtual Direct™ Highlights

2020 ASCO Follow Up on Advanced Melanoma: Should We Consider TIL as …

Feat. M. Orloff
13:04
2020 ASCO Virtual Direct™ Highlights

2020 ASCO Update on Metastatic Melanoma: Is Toripalimab + Axitinib a…

Feat. M. Orloff